November 14th, 2026ObesityWeek 2026: Studies Map GLP-1 Access Gaps, Obesity's CostsResearch at ObesityWeek 2026 tracks rising obesity in Medicare, productivity losses, prior authorization denials, and GLP-1 persistence.Read more
November 18th, 2026Low CRC Incidence Found After Endoscopic Mucosal ResectionCRC diagnoses after endoscopic mucosal resection (EMR) were uncommon in a real-world cohort, though racial and ethnic differences remain unclear.Read more
November 17th, 2026Real-World Data Support Cemiplimab Efficacy in Advanced NSCLCIn this Q&A, Jesús Corral Jaime, MD, discusses real-world CEMI-LUNG data on cemiplimab in advanced NSCLC presented at the ESMO 2026 Congress.Read more
November 19th, 2026New Employer Guide Maps Diabetes Prevention, Care ResourcesAn employer coalition's new guide outlines how workplaces can prevent and manage diabetes, from benefit design to accommodations.Read more
November 18th, 2026FDA Approves Secukinumab as First Anti–IL-17 Biologic for PMRThe FDA has approved secukinumab for PMR after the REPLENISH trial showed doubled sustained remission and lower steroid use vs a steroid taper alone.Read more
November 17th, 2026FDA Grants Accelerated Approval to Neladalkib for Previously Treated ALK-Positive NSCLCNeladalkib earned accelerated approval for previously treated ALK-positive NSCLC, with ORRs of 49% and 32%.Read more
November 17th, 2026Precision Medicine Equity Hinges on Systems, but Coverage Gaps Linger Panelists concurred that precision medicine can serve to exacerbate care inequality if not everyone can access these therapeutics. Read more
November 16th, 2026Shorter US Residence Linked to Greater CRC Screening NonadherenceNon-US-born adults had higher CRC screening nonadherence than US-born adults, particularly those with less than 15 years of US residence.Read more